Improved treatment completion with shorter treatment regimens for latent tuberculous infection
Supporting Files
-
November 2018
-
Available in CDC Stacks on 2019-11-01T00:00:00Z
File Language:
English
Details
-
Journal Article:Int J Tuberc Lung Dis
-
Personal Author:
-
Description:SETTING: ; Four New York City (NYC) Health Department tuberculosis (TB) clinics. ; OBJECTIVE: ; To assess the effectiveness of preferentially offering two shorter treatment regimens—4 months of daily rifampin (4R) and 3 months of once-weekly isoniazid and rifapentine (3HP)—as an alternative to 9 months of daily isoniazid (9H) for the treatment of latent tuberculous infection (LTBI). ; DESIGN: ; Retrospective analysis of patients treated for LTBI from January to June 2015. Poisson regression with robust standard error was used to examine the factors associated with treatment completion. ; RESULTS: ; Of the patients on 9H, 49% (27/55) completed treatment compared with 70% (187/269) of patients on 4R (P=0.003) and 79% (99/125) of patients on 3HP (P < 0.001). When adjusting for age, sex, and TB risk factors, patients on 4R (adjusted risk ratio aRR 1.39, 95%CI 1.07–1.81) and 3HP (aRR 1.67, 95%CI 1.27–2.19) were more likely to complete treatment than patients on 9H. Treatment was discontinued due to side effects in 1% (3/269) of patients on 4R, 2% (2/125) of patients on 3HP, and 4% (2/55) of patients on 9H. ; CONCLUSIONS: ; Most patients were placed on shorter regimens for LTBI treatment, and higher treatment completion was observed. Encouraging community providers to use shorter regimens for LTBI treatment would reduce the TB disease burden in NYC.
-
Subjects:
- Article
- LTBI
- 4R
- 3HP
- adherence
- Adolescent
- Adult
- Aged
- Aged, 80 and over
- Antitubercular Agents
- Child
- Child, Preschool
- Directly Observed Therapy
- Drug Administration Schedule
- Drug Therapy, Combination
- Drug-Related Side Effects and Adverse Reactions
- Female
- Humans
- Infant
- Infant, Newborn
- Isoniazid
- Latent Tuberculosis
- Male
- Medication Adherence
- Middle Aged
- New York City
- Retrospective Studies
- Rifampin
- Risk Factors
- Time Factors
- Treatment Outcome
- Young Adult
-
Source:Int J Tuberc Lung Dis. 22(11):1344-1349
-
DOI:
-
Pubmed ID:30355415
-
Pubmed Central ID:PMC6309173
-
Document Type:
-
Funding:
-
Genre:
-
Volume:22
-
Issue:11
-
Download URL:
-
File Type:
-
Collection(s):
-
Main Document Checksum:urn:sha-512:401e360d188f0881cb6317419063d381221f34880f0934d4ad6a5bb174b2b299c18c78ee26cd0602269e657e8a62b96b351f82ae36af581cfd21e9df2a56e8fc
Supporting Files
File Language:
English
CDC STACKS serves as an archival repository of CDC-published products including
scientific findings, journal articles, guidelines, recommendations, or other public health information authored or
co-authored by CDC or funded partners.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
As a repository, CDC STACKS retains documents in their original published format to ensure public access to scientific information.
You May Also Like
COLLECTION
CDC Public Access